On ECHEMI
Home > Drugs > Cervical cancer
Cervical cancer
Cervical cancer is the only gynecological malignancy with a clear etiology, and is associated with persistent infection with high-risk human papillomavirus. HPV is a double-stranded DNA virus that mainly infects the epithelium of the skin and mucous membranes, causing different lesions. Other high-risk factors include: 1. Sexual behavior: starting sexual life too early, multiple sexual partners; 2. Menstrual and childbirth factors: poor menstrual hygiene, prolonged menstruation, early childbearing, multiple births, etc.; 3. Smoking; 4. Long-term use of oral contraceptives, etc. The earliest symptoms are mainly vaginal bleeding and vaginal discharge. It is the third most common malignant tumor among women worldwide, second only to breast cancer and colorectal cancer.
  • Site of disease:

    Uterus
  • Infectious :

    Not contagious
  • Frequent population:

    Women aged 40 to 60, in the sexually active period...
  • Related symptoms:

    Purulent and bloody leucorrhea weight loss nipple-like hyperplasia changes continuous vaginal bleeding vaginal metastasis
  • Concurrent disease:

Related Drugs
Xiao Cancer Tablets
Manufacturer:

Shaanxi Junshoutang Pharmaceuical Co., Ltd.

Xiaoaiping Syrup
Manufacturer:

Jilin Changbai Mountain Pharmaceutical Group Co., Ltd.

Xiao Cancer Tablets
Manufacturer:

Hunan Warrant Pharmaceutical Co., Ltd.

Xiao Cancer Tablets
Manufacturer:

Jiangxi Jurentang Pharmaceutical Co., Ltd.

Xiaoaiping oral liquid
Manufacturer:

YangLing Charisma Biopharmaceutical Co., Ltd.

Xiao Cancer Tablets
Manufacturer:

Guangdong Xiantong Pharmaceutical Co., Ltd.

Xiao Cancer Tablets
Manufacturer:

Shaanxi Momide Qixue and Pharmaceutical Co., Ltd.

Xiao Cancer Tablets
Manufacturer:

Shaanxi Jingfeng Pharmaceutical Co., Ltd.

Xiao Cancer Tablets
Manufacturer:

Shaanxi Jingfeng Pharmaceutical Co., Ltd.

Related Ingredients
  • 1,10-Phenanthroline hydrate list

    5144-89-8
  • Dracaenoside F list

    477336-77-9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.